(Q24234000)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328294%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

0 references

1 reference

title

Lifestyle changes in women with polycystic ovary syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328294%20AND%20SRC:MED&resulttype=core&format=json

polycystic ovary syndrome

22 January 2020

main subject

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328294%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Helena Teede

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328294%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

3

Robert J Norman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328294%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Samantha K Hutchison

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328294%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

16 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328294%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328294%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328294%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

CD007506

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328294%20AND%20SRC:MED&resulttype=core&format=json

Effects of exercise on lipoprotein particles in women with polycystic ovary syndrome

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Effects of exercise and nutritional counseling in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Effect of weight loss and antiandrogenic therapy on sex hormone blood levels and insulin resistance in obese patients with polycystic ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

The prevalence and features of the polycystic ovary syndrome in an unselected population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

The effects of exercise interventions on quality of life in clinical and healthy populations; a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Dietary therapy in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Exercise or exercise and diet for preventing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Polycystic ovary syndrome is associated with endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Insulin resistance: the link between obesity and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

The management of insulin resistance in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

Analysing Data and Undertaking Meta-Analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007506.PUB2

10.1002/14651858.CD007506.PUB2

21 January 2018

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3373666

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328294%20AND%20SRC:MED&resulttype=core&format=json

OpenCitations bibliographic resource ID

22 January 2020

3373666

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference